Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-29
2005-03-29
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S041000, C548S416000, C514S443000, C514S279000
Reexamination Certificate
active
06872746
ABSTRACT:
The present invention is directed to novel fused pyrrolocarbazoles and isoindolones, including pharmaceutical compositions, diagnostic kits, assay standards or reagents containing the same, and methods of using the same as therapeutics. The invention is also directed to intermediates and processes for making these novel compounds.
REFERENCES:
patent: 4735939 (1988-04-01), McCoy et al.
patent: 4816450 (1989-03-01), Bell et al.
patent: 4877776 (1989-10-01), Murakata et al.
patent: 4923986 (1990-05-01), Murakata et al.
patent: 5063330 (1991-11-01), Leprince et al.
patent: 5516771 (1996-05-01), Dionne et al.
patent: 5545636 (1996-08-01), Heath, Jr. et al.
patent: 5552396 (1996-09-01), Heath, Jr. et al.
patent: 5616724 (1997-04-01), Hudkins et al.
patent: 5621101 (1997-04-01), Lewis et al.
patent: 5672618 (1997-09-01), Heath, Jr. et al.
patent: 5705511 (1998-01-01), Hudkins et al.
patent: 5710145 (1998-01-01), Engel et al.
patent: 5808060 (1998-09-01), Hudkins et al.
patent: 6635669 (2003-10-01), Hudkins
patent: WO 9807433 (1998-02-01), None
Bergman, J.Tetrahedron1999, 55 (8), 2363-2370.
Cephalon Inc.
Desai Rita
Hrubiec Robert T.
Larsen Scott K.
Voelk Eric K.
LandOfFree
Isomeric fused pyrrolocarbazoles and isoindolones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isomeric fused pyrrolocarbazoles and isoindolones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isomeric fused pyrrolocarbazoles and isoindolones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3376258